Franklin M. Berger
Director · Retension Pharmaceuticals, Inc.
- 2024
- Oct 13, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Franklin M. Berger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric L. Keller - $250K in RTSN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Franklin M. Berger?
Franklin M. Berger is a corporate insider, tracked as Director of Retension Pharmaceuticals, Inc. (RTSN). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Franklin M. Berger submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Franklin M. Berger been buying or selling stock?
Recorded transactions: 1 open-market purchase ($120K) and 1 open-market sale ($1.02M) across all tracked filings.
